Using blood tests to monitor and improve treatment for multiple myeloma
Liquid Biopsy in Myeloma to Inform Outcome and Treatment Decisions
['FUNDING_R37'] · UNIVERSITY OF UTAH · NIH-11243248
This study is looking at a new, easier way to keep track of multiple myeloma by using blood tests instead of the more painful bone marrow biopsies, so patients can get important updates about their cancer without the stress of invasive procedures.
Quick facts
| Phase | ['FUNDING_R37'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF UTAH (nih funded) |
| Locations | 1 site (SALT LAKE CITY, UNITED STATES) |
| Trial ID | NIH-11243248 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a less invasive method to monitor multiple myeloma, a type of blood cancer, by using liquid biopsies instead of traditional bone marrow biopsies. Liquid biopsies involve analyzing circulating myeloma cells and cell-free DNA from a simple blood draw, which can provide more comprehensive insights into the disease's evolution and treatment response. This approach aims to reduce the burden of repeated invasive procedures on patients while ensuring that treatment decisions are based on the most current information about the cancer's status.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with multiple myeloma who are undergoing treatment.
Not a fit: Patients with other types of blood cancers or those who are not currently receiving treatment for multiple myeloma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment strategies for patients with multiple myeloma, improving their outcomes and quality of life.
How similar studies have performed: Other research has shown promise in using liquid biopsies for cancer monitoring, indicating that this approach could be a significant advancement in the field.
Where this research is happening
SALT LAKE CITY, UNITED STATES
- UNIVERSITY OF UTAH — SALT LAKE CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LOHR, JENS G — UNIVERSITY OF UTAH
- Study coordinator: LOHR, JENS G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Blood Diseases, blood disorder